Cargando…
Novel Immune Checkpoints in Esophageal Cancer: From Biomarkers to Therapeutic Targets
Esophageal cancer ranks as the sixth most common cause of cancer death worldwide. Due to the limited efficacy of conventional therapeutic strategies, including surgery, chemotherapy, and radiotherapy, treatments are still far from satisfactory in terms of survival, prompting the search for novel tre...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163322/ https://www.ncbi.nlm.nih.gov/pubmed/35669786 http://dx.doi.org/10.3389/fimmu.2022.864202 |